LA CREME P- octinoxate avobenzone titanium dioxide cream

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51), AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX), TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)

Available from:

Zenith Medicosm SL

INN (International Name):

OCTINOXATE

Composition:

OCTINOXATE 3.75 mL in 50 mL

Administration route:

TOPICAL

Prescription type:

OTC DRUG

Therapeutic indications:

Luxurious facial moisturizer that combats skin ageing and ensures that skin is well nourished and moisturized round-the clock. Its formula is rich in active ingredients that help provide optimum conditions for the natural function of collagen and elastin in the skin.  La Creme helps reduce expression lines and wrinkles and improves the skin's flexibility and elasticity.  Skin looks firmer and more luminous.  Within days of using it there will be a visible improvement. 50ml. 1.7fl. oz.

Authorization status:

OTC monograph not final

Summary of Product characteristics

LA CREME P- OCTINOXATE AVOBENZONE TITANIUM DIOXIDE CREAM
ZENITH MEDICOSM SL
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may be marketed if they_
_comply with applicable regulations and policies. FDA has not
evaluated whether this product complies._
----------
DRUG FACTS
ACTIVE INGREDIENT
Octinoxate 7.5%
Avobenzone 3%
Titanium Dioxide 25%
DES CRIPTION
Luxurious facial moisturizer that combats skin ageing and ensures that
skin is well nourished and
moisturized round-the clock. Its formula is rich in active ingredients
that help provide optimum
conditions for the natural function of collagen and elastin in the
skin. La Creme helps reduce
expression lines and wrinkles and improves the skin's flexibility and
elasticity. Skin looks firmer and
more luminous. Within days of using it there will be a visible
improvement.
50ml. 1.7fl. oz.
LA CREME P
octinoxate avobenzone titanium dioxide cream
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:42248 -133
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
O CTINO XATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)
OCTINOXATE
3.75 mL in 50 mL
AVO BENZO NE (UNII: G6 3QQF2NOX) (AVOBENZONE - UNII:G6 3QQF2NOX)
AVOBENZONE
1.5 mL in 50 mL
TITANIUM DIO XIDE (UNII: 15FIX9 V2JP) (TITANIUM DIOXIDE - UNII:15FIX9
V2JP)
TITANIUM DIOXIDE
12.5 mL in 50 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
MAGNESIUM ALUMINUM SILICATE (UNII: 6 M3P6 4V0 NC)
PRO PYLPARABEN (UNII: Z8 IX2SC1OH)
ALPHA-TO CO PHERO L ACETATE (UNII: 9 E8 X8 0 D2L0 )
DIMETHICO NE (UNII: 9 2RU3N3Y1O)
XANTHAN GUM (UNII: TTV12P4NEE)
SHEA BUTTER (UNII: K49 155WL9 Y)
WATER (UNII: 0 59 QF0 KO0 R)
ISO PRO PYL PALMITATE (UNII: 8 CRQ2TH6 3M)
TRICAPRYLIN (UNII: 6 P9 28 58 9 8 8 )
PEG-8 STEARATE (UNII: 2P9 L47VI5E)
SILICO N DIO XIDE (UNII: ETJ7Z6 XBU4)
PRO PYLENE GLYCO L (UNII: 6 DC9 Q16 7V3)
CHO NDRUS CRISPUS (UNII: OQS23HUA1X)
BUTYLATED HYDRO XYTO LUENE (UNII: 1P9 D0 Z171K)
ASCO RBYL PALMITATE (UNII: QN8 3US2B0 N